Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Vascular Destabilization and Pericyte Detachment are Mediated by hIAPP Aggregation in Transgenic Mice
J Koepke, L Mateus Gonçalves, C Andrade Barboza, et al.
Acta Ortopedica Mexicana
|
March 8, 2017
[Results of percutaneous discectomy in the management of lumbar disc herniation]
P G Lima-Ramírez, A J Montiel-Jarquín, R G Barragán-Hervella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2014
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy
J S Abramson, T Feldman, A R Kroll-Desrosiers, et al.
Blood Cancer Journal
|
April 15, 2025
Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis
Y Sawalha, S Sarosiek, R L Welkie, et al.
Leukemia
|
July 4, 2015
Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia
I M Ghobrial, R Redd, P Armand, et al.
British Journal of Haematology
|
September 19, 2024
ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells
M Munshi, X Liu, A Kofides, et al.
Seminars in Hematology
|
May 5, 2023
Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients
S D'Sa, J V Matous, R Advani, et al.
Seminars in Hematology
|
April 26, 2023
Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials
C S Tam, P Kapoor, J J Castillo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Vascular Destabilization and Pericyte Detachment are Mediated by hIAPP Aggregation in Transgenic Mice
J Koepke, L Mateus Gonçalves, C Andrade Barboza, et al.
Acta Ortopedica Mexicana
|
March 8, 2017
[Results of percutaneous discectomy in the management of lumbar disc herniation]
P G Lima-Ramírez, A J Montiel-Jarquín, R G Barragán-Hervella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2014
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy
J S Abramson, T Feldman, A R Kroll-Desrosiers, et al.
Blood Cancer Journal
|
April 15, 2025
Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis
Y Sawalha, S Sarosiek, R L Welkie, et al.
Leukemia
|
July 4, 2015
Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia
I M Ghobrial, R Redd, P Armand, et al.
British Journal of Haematology
|
September 19, 2024
ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells
M Munshi, X Liu, A Kofides, et al.
Seminars in Hematology
|
May 5, 2023
Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients
S D'Sa, J V Matous, R Advani, et al.
Seminars in Hematology
|
April 26, 2023
Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials
C S Tam, P Kapoor, J J Castillo, et al.
Page
of 2